References
- Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int. 2008;74:860–866.
- Lin SL, Li B, Rao S, et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA. 2010;107:4194–4199.
- Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210.
- Guarino M, Tosoni A, Nebuloni M. Direct contribution of epithelium to organ fibrosis: Epithelial–mesenchymal transition. Hum Pathol. 2009;40:1365–1376.
- Jiang T, Huang B, Chen PS, et al. Epithelial–mesenchymal transition of renal tubules: Divergent processes of repairing in acute or chronic injury? Med Hypotheses. 2013;81:73–75.
- Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs. 2007;185:222–231.
- Wang Q, Usinger W, Nichols B, et al. Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease.. Fibrogenesis Tissue Repair. 2011;4:4.
- Yeh YC, Wei WC, Wang YK, et al. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol. 2010;177:1743–1754.
- Zeng R, Han M, Luo Y, et al. Role of Sema4C in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial–mesenchymal transition in renal tubular epithelial cells. Nephrol Dial Transplant. 2011;26:1149–1156.
- El Messaoudi S, Rongen GA, de Boer RA, et al. The cardioprotective effects of metformin. Curr Opin Lipidol. 2011;22:445–453.
- Lin A, Sekhon C, Sekhon B, et al. Attenuation of ischemia–reperfusion injury in a canine model of autologous renal transplantation. Transplantation. 2004;78:654–659.
- Seo-Mayer PW, Thulin G, Zhang L, et al. Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. Am J Physiol Renal Physiol. 2011;301:F1346–F1357.
- Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, et al. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis. Cell Cycle. 2010;9:4461–4468.
- Xiao H, Ma X, Feng W, et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res. 2010;87:504–513.
- Lee MJ, Feliers D, Mariappan MM, et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007;292:F617–F627.
- de Oliveira CP, Stefano JT, de Siqueira ER, et al. Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res. 2008;38:159–165.
- Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349:2326–2333.
- Guo G, Morrissey J, McCracken R, et al. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol. 1999;277:F766–F772.
- Meldrum KK, Misseri R, Metcalfe P, et al. TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1456–R1464.
- Dong R, Wang Q, He XL, et al. Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial–mesenchymal transition of MCF-7 cells. Braz J Med Biol Res. 2007;40:1071–1078.
- Chaudhuri V, Zhou L, Karasek M. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: A potential role in skin fibrogenesis. J Cutan Pathol. 2007;34:146–153.
- Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest. 2003;112:1486–1494.
- Misseri R, Rink RC, Meldrum DR, et al. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res. 2004;119:149–159.
- Peairs A, Radjavi A, Davis S, et al. Activation of AMPK inhibits inflammation in MRL/Lpr mouse mesangial cells. Clin Exp Immunol. 2009;156:542–551.
- Lee JH, Kim JH, Kim JS, et al. AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am J Physiol Renal Physiol. 2013;304:F686–F697.